𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Case–control study of multiple system atrophy

✍ Scribed by Nicola Vanacore; Vincenzo Bonifati; Giovanni Fabbrini; Carlo Colosimo; Giuseppe De Michele; Roberto Marconi; Fabrizio Stocchi; David Nicholl; Ubaldo Bonuccelli; Michele De Mari; Peter Vieregge; Giuseppe Meco


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
70 KB
Volume
20
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The epidemiology of multiple system atrophy (MSA) is scarcely known, and risk factors have not been definitely identified. We investigated the effect of family history for neurodegenerative diseases and environmental factors on MSA risk in a multicentric case–control study. A total of 73 MSA patients (42 men, 31 women; age, 64.3 ± 8.1 years; disease duration, 4.8 ± 3.9 years), 146 hospital controls (84 men, 62 women; age, 64.9 ± 8.4 years), and 73 population controls (42 men, 31 women; age, 63.7 ± 8.9 years) matched for sex, age (±3 years), and province of residence were enrolled consecutively at seven neurological centers from 1 January 1994 to 31 July 1998. The following variables were investigated: family history of neurodegenerative diseases, education, smoking habits, hobbies, and occupational history. Occupational history of farming was significantly more frequent among MSA cases than controls (OR adj = 2.52; 95% CI, 1.25 to 5.07, MSA vs. hospital controls; OR adj = 4.53; 95% CI, 1.68 to12.2, MSA cases vs. population controls). A dose–response analysis for years of farming corroborated this association. We recently found that smoking is significantly less frequent among MSA cases than controls (Vanacore et al. [2000] Neurology 54:114–119). Here, we report that the effects of farming and smoking on MSA risk do not interact. Our results suggest that occupational history of farming is a risk factor for MSA. Smoking and farming seem to influence MSA risk independently. Further epidemiological studies might provide clues on the etiopathogenesis of MSA. © 2004 Movement Disorder Society


📜 SIMILAR VOLUMES


A case–control study of multiple system
✍ Joo-Hyun Seo; Seok Woo Yong; Sook K. Song; Ji E. Lee; Young H. Sohn; Phil Hyu Le 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## Abstract A few case–control studies of multiple system atrophy (MSA) have been reported in Western populations. In this study, we included various epidemiological factors to evaluate whether the risk factors for MSA differed in Korean and Western populations. A total of 100 consecutive MSA patie

Risk factors of multiple system atrophy:
✍ Jean-Sébastien Vidal; Marie Vidailhet; Alexis Elbaz; Pascal Derkinderen; Christo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## Abstract Multiple system atrophy (MSA) is a rare sporadic progressive neurodegenerative disorder. MSA risk factors are poorly known. The objectives of this case‐control study were to study environmental risk factors associated with MSA. Cases were recruited through five French referral centers.

Serum cholesterol levels and the risk of
✍ Phil Hyu Lee; Tae Sung Lim; Hae-Won Shin; Seok Woo Yong; Hyo Suk Nam; Young H. S 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 1 views

## Abstract Cholesterol in brain membranes may modulate the conformational state and accumulation of α‐synuclein in α‐synucleinopathies.We examined the association between serum cholesterol and the risk of multiple system atrophy (MSA), one of the α‐synucleinopathies. We enrolled 142 patients with

Brainstem respiratory control: Substrate
✍ Eduardo E. Benarroch 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

## Abstract Multiple system atrophy may manifest with severe respiratory disorders, including sleep apnea and laryngeal stridor, which reflect a failure of automatic control of respiration. This function depends on a pontomedullary network of interconnected neurons located in the parabrachial/Kölli

Presynaptic parkinsonism in multiple sys
✍ José Berciano; Francesc Valldeoriola; Isidre Ferrer; Jordi Rumià; Julio Pascual; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 318 KB

We describe the clinicopathological findings in a patient aged 63 years at death who, at age 55 years, developed levodopa-responsive parkinsonism with no atypical features. A diagnosis of idiopathic Parkinson's disease (PD) was made. During the clinical course, fluctuations and dyskinesias appeared.